Subscribe to MDT Magazine News

Echo Therapeutics Expands Into New Headquarters in Philadelphia

May 5, 2011 6:38 am | by Bio-Medicine.Org | Comments

PHILADELPHIA, May 5, 2011 /- Echo Therapeutics, Inc. (OTCBB: ECTE), a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, today...


Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products

May 5, 2011 6:37 am | by Bio-Medicine.Org | Comments

REDWOOD CITY, Calif., May 5, 2011 /- Pearl Therapeutics Inc. made three presentations at the Respiratory Drug Delivery Europe (RDD Europe 2011) meeting in Berlin this week elucidating the tunability, versatility and universality of the Company's porous particle-based metered dose inhaler...


Quest Diagnostics Launches Simplexaâ„¢ C. Difficile Universal Direct Test in Europe

May 5, 2011 6:36 am | by Bio-Medicine.Org | Comments

MADISON, N.J. and CYPRESS, Calif., May 5, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, today announced the availability in Europe of the Simplexa C. difficile Universal Direct test on the 3M™...


IPG sales increase 95% in Q1

May 5, 2011 4:37 am | by I-Micronews | Comments

IPG Photonics, a producer of fiber lasers and amplifiers, announced a 95 percent increase in sales in the first quarter of 2011, as compared to a year ago.

Boston Scientific Offers New CRT-D Warranty Program Covering Phrenic Nerve Stimulation

May 5, 2011 4:35 am | by Boston Scientific | Comments

NATICK, Mass., May 5, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it is offering a new warranty program in the U.S. that covers its cardiac resynchronization therapy defibrillator (CRT-


Reportlinker Adds Minimally Invasive Surgical Devices, World Market

May 5, 2011 3:47 am | by Bio-Medicine.Org | Comments

NEW YORK, May 5, 2011 /- announces that a new market research report is available in its catalogue: Minimally Invasive Surgical Devices, World Market Minimally invasive surgery (MIS)...


Acorda 1Q loss narrows on Ampyra sales

May 5, 2011 3:45 am | by The Associated Press | Comments

Drugmaker Acorda Therapeutics Inc. said Thursday that its first-quarter loss narrowed on a surge in sales of the multiple sclerosis drug Ampyra.The company reported a net loss of $672,000, or 2 cents per share, for the three months ended March 31 compared with a net loss of $21.1 million, or 56...

Concord Medical to Report First Quarter 2011 Financial Results on Wednesday, May 18, 2011

May 5, 2011 3:40 am | by Bio-Medicine.Org | Comments

BEIJING, May 5, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical") (NYSE: CCM ), operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it will report its unaudited financial results for...


Insurer Cigna's 1Q profit soars 52 percent

May 5, 2011 2:45 am | by The Associated Press | Comments

Cigna says its first-quarter net income jumped 52 percent, as the managed care company saw strong earnings growth from all of its businesses.The Philadelphia insurer earned $429 million, or $1.57 per share, in the three months that ended March 31. That's up from the $283 million, or $1.02 per...

Ridge Diagnostics, Inc. CEO to Speak at Neurotech Investing and Partnering Conference

May 5, 2011 2:33 am | by Bio-Medicine.Org | Comments

SAN DIEGO, May 5, 2011 /- Ridge Diagnostics, Inc., a neurodiagnostic company, announced that Lonna J. Williams, CEO will speak at the 6th Annual Neurotech Investing and Partnering Conference to be held in San Francisco, CA at the St. Regis Hotel on May 9th and 10th.   Ms. Williams, a...


GRAPHENE-CA appointed an EU future emerging technology flagship pilot

May 4, 2011 11:41 pm | by I-Micronews | Comments

A coordination action on graphene will be funded by the European Commission to develop plans for a 10-year, 1,000 million euro FET flagship.

New CE Marked Test Simultaneously Detects Up To 95% of Gastrointestinal Infections in Under Five Hours

May 4, 2011 10:40 pm | by Bio-Medicine.Org | Comments

AUSTIN, Texas and MILAN, May 5, 2011 /- Luminex Corporation (NASDAQ: LMNX ) announced today that it has received CE marking for its new xTAG Gastrointestinal Pathogen Panel (GPP).This innovative assay is the first test of its kind to help identify up to 95 percent of the disease causing...


New algorithm significantly improves imaging for full-body MRIs

May 4, 2011 10:37 pm | by EurekAlert | Comments

(American Roentgen Ray Society) A new study reveals an improved algorithm that can dramatically improve how radiologists capture and interpret full-body MRIs, particularly in the abdominal region.


Racial Disparities Still Exist in Colorectal Cancer Screening Despite Increased Medicare Coverage

May 4, 2011 10:36 pm | by AACR | Comments

Tweet • Blacks and Hispanics less likely than whites to receive screening. • Disparities persisted after increased colorectal screening coverage. PHILADELPHIA - Despite expanded Medicare coverage for colorectal cancer screening tests, lower rates still exist among blacks and Hispanics...


Accounting change lifts NuVasive 1Q profit

May 4, 2011 2:45 pm | by The Associated Press | Comments

Medical device maker NuVasive Inc. said Wednesday its profit grew in the first quarter because of a change in its accounting procedures and an increase in revenue.The company said its profit more than doubled to $2.4 million, or 6 cents per share, from $1.1 million, or 3 cents per share....


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.